Remove 2007 Remove Pharmaceutical Remove Sourcing
article thumbnail

Gen Phoenix Partners With Axil to Support Sustainability Goals

MEM

Axil is also improving recycling processes within the Gen Phoenix office and factory, allowing them to increase even further the recycling levels at the source. Since 2007, Gen Phoenix has diverted thousands of tons of material from landfill.

article thumbnail

Fusing biology with the bionic ear

E&T

These cells are like ‘keys on a piano’ and range from low to high frequency, explains Dr Robert Gay, director of pharmaceutical approaches at Cochlear, a Sydney-based manufacturer of the device. The research, which started in 2007, is based on an optogenetics method that emerged around the millennium and has been shown to work in rodents.

article thumbnail

Building an Integrated, End-to-End R&D and Manufacturing Service Platform with Innovative R&D and High-end Preparation Technologies

Frost & Sullivan Manufacturing

Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Therefore, for pharmaceutical companies, high-end preparations represent a high-value, cost-effective strategy for differentiation.